18 September 2024: We’re thrilled to announce the release of globally significant results from the AGITG TOPGEAR study on which TROG collaborated, providing practice-changing evidence about preoperative chemoradiotherapy for gastric cancer. The findings, announced simultaneously at the European Society for Medical Oncology Congress in Barcelona, Spain and published in
11 September 2024: Our 2024 Annual Scientific Meeting was a vital platform for advancing cutting-edge research in radiation therapy and enhancing collaboration among researchers from Australia, New Zealand and beyond. More than 250 delegates joined together for the TROG Cancer Research 36th ASM, held in our hometown of Newcastle,
The 2023 TROG Cancer Research Annual Report details achievements including strengthened collaborations and growth in membership.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
